RJT
BSX icon

Raymond James Trust’s Boston Scientific BSX Stock Holding History

Raymond James Trust’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.79M Sell
21,343
-45
-0.2% -$3.55K 0.04% 346
2024
Q2 		$1.65M Buy
21,388
+4,324
+25% +$316K 0.04% 351
2024
Q1 		$1.17M Buy
17,064
+96
+0.6% +$6.17K 0.03% 427
2023
Q4 		$981K Buy
16,968
+1,187
+8% +$63.4K 0.03% 463
2023
Q3 		$833K Buy
15,781
+2,048
+15% +$107K 0.02% 468
2023
Q2 		$743K Buy
13,733
+2,244
+20% +$117K 0.02% 508
2023
Q1 		$575K Buy
11,489
+349
+3% +$16.4K 0.02% 580
2022
Q4 		$516K Sell
11,140
-752
-6% -$32.6K 0.02% 588
2022
Q3 		$461K Sell
11,892
-2,507
-17% -$101K 0.02% 605
2022
Q2 		$536K Buy
14,399
+293
+2% +$11.9K 0.02% 569
2022
Q1 		$625K Sell
14,106
-4,286
-23% -$186K 0.02% 552
2021
Q4 		$781K Sell
18,392
-1,628
-8% -$68.4K 0.02% 495
2021
Q3 		$868K Buy
20,020
+10
+0% +$442 0.03% 443
2021
Q2 		$856K Buy
20,010
+4,400
+28% +$185K 0.03% 439
2021
Q1 		$603K Buy
15,610
+2,997
+24% +$113K 0.02% 522
2020
Q4 		$453K Buy
12,613
+969
+8% +$34.9K 0.02% 582
2020
Q3 		$445K Sell
11,644
-106
-0.9% -$4.08K 0.02% 528
2020
Q2 		$412K Buy
11,750
+310
+3% +$11.2K 0.02% 530
2020
Q1 		$373K Sell
11,440
-292
-2% -$11.4K 0.02% 478
2019
Q4 		$530K Buy
11,732
+1,415
+14% +$59.2K 0.03% 447
2019
Q3 		$420K Buy
10,317
+3,624
+54% +$154K 0.02% 517
2019
Q2 		$287K Buy
6,693
+363
+6% +$14K 0.02% 642
2019
Q1 		$243K Sell
6,330
-840
-12% -$32.1K 0.01% 692
2018
Q4 		$253K Buy
7,170
+866
+14% +$31.4K 0.02% 626
2018
Q3 		$243K Buy
+6,304
New +$220K 0.01% 725

Other funds holding BSX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Raymond James Trust's BSX Position: Q3 2024 in Review

Raymond James Trust reduced its Boston Scientific (BSX) stake by 0.21% in Q3 2024, selling an estimated $3.55K and leaving 21,343 shares worth $1.79M. The position accounts for 0.04% of the portfolio, ranked #346.

Raymond James Trust first reported a position in BSX in Q3 2018 and has held it in 25 quarters since. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Raymond James Trust held 21,343 shares of Boston Scientific worth $1.79M as of Q3 2024.
  • Raymond James Trust sold 45 Boston Scientific shares in Q3 2024, an estimated $3.55K.
  • Boston Scientific made up 0.04% of Raymond James Trust's portfolio in Q3 2024, its #346 holding.
  • Raymond James Trust first reported a position in Boston Scientific in Q3 2018 and has held it in 25 quarters since.
  • 1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.